Research on the biological properties of cow urine and its distillate (Arka) has led to groundbreaking findings in agriculture and healthcare. Scientific studies, primarily conducted by CSIR-CIMAP and other prestigious institutions, highlight that cow urine enhances the efficacy of antibiotics like Rifampicin and Ampicillin and improves the anticancer activity of drugs like Taxol. Key discoveries have resulted in three U.S. patents (6,410,059; 6,896,907; 7,235,262) showcasing its antimicrobial, anticancer, and bioenhancer properties.

Additionally, studies confirm cow urine's immunomodulatory effects, antioxidant properties, and potential to combat oxidative stress and bacterial resistance. Research also underscores its applications in sustainable agriculture as bio-fertilizers, pesticides, and disinfectants. Factors like breed, collection time, and fodder impact its chemical composition and efficacy. The establishment of national research facilities under programs like SVAROP and SUTRA-PIC ensures standardisation, furthering innovation and commercial utilisation of Panchgavya products.

This research empowers advancements in health, agriculture, and sustainable living, promoting the multifaceted benefits of indigenous cow-based products.